Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 8;25(2):776.
doi: 10.3390/ijms25020776.

The Multifaceted S100B Protein: A Role in Obesity and Diabetes?

Affiliations
Review

The Multifaceted S100B Protein: A Role in Obesity and Diabetes?

Fabrizio Michetti et al. Int J Mol Sci. .

Abstract

The S100B protein is abundant in the nervous system, mainly in astrocytes, and is also present in other districts. Among these, the adipose tissue is a site of concentration for the protein. In the light of consistent research showing some associations between S100B and adipose tissue in the context of obesity, metabolic disorders, and diabetes, this review tunes the possible role of S100B in the pathogenic processes of these disorders, which are known to involve the adipose tissue. The reported data suggest a role for adipose S100B in obesity/diabetes processes, thus putatively re-proposing the role played by astrocytic S100B in neuroinflammatory/neurodegenerative processes.

Keywords: S100B protein; adipose tissue; diabetes; obesity.

PubMed Disclaimer

Conflict of interest statement

Author F.M. was employed by the company Genes. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the paracrine loop involving S100B between adipocytes and macrophages in the development of fatty tissue dysfunction. During obesity processes, adipocytes might release S100B, which acts in a paracrine manner, as an adipokine. In a RAGE-mediated manner, S100B upregulates in macrophages inflammatory cytokines, which, in turn, can stimulate S100B release from adipocytes thus sustaining inflammation via macrophage stimulation.
Figure 2
Figure 2
High levels of S100B are associated with several non-neurological metabolic disorders.

References

    1. Michetti F., D’Ambrosi N., Toesca A., Puglisi M.A., Serrano A., Marchese E., Corvino V., Geloso M.C. The S100B Story: From Biomarker to Active Factor in Neural Injury. J. Neurochem. 2019;148:168–187. doi: 10.1111/jnc.14574. - DOI - PubMed
    1. Michetti F., Di Sante G., Clementi M.E., Sampaolese B., Casalbore P., Volonté C., Romano Spica V., Parnigotto P.P., Di Liddo R., Amadio S., et al. Growing Role of S100B Protein as a Putative Therapeutic Target for Neurological- and Nonneurological-Disorders. Neurosci. Biobehav. Rev. 2021;127:446–458. doi: 10.1016/j.neubiorev.2021.04.035. - DOI - PubMed
    1. Michetti F., Clementi M.E., Di Liddo R., Valeriani F., Ria F., Rende M., Di Sante G., Romano Spica V. The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker. IJMS. 2023;24:9605. doi: 10.3390/ijms24119605. - DOI - PMC - PubMed
    1. Jaacks L.M., Vandevijvere S., Pan A., McGowan C.J., Wallace C., Imamura F., Mozaffarian D., Swinburn B., Ezzati M. The Obesity Transition: Stages of the Global Epidemic. Lancet Diabetes Endocrinol. 2019;7:231–240. doi: 10.1016/S2213-8587(19)30026-9. - DOI - PMC - PubMed
    1. Vekic J., Zeljkovic A., Stefanovic A., Jelic-Ivanovic Z., Spasojevic-Kalimanovska V. Obesity and Dyslipidemia. Metabolism. 2019;92:71–81. doi: 10.1016/j.metabol.2018.11.005. - DOI - PubMed

Substances

LinkOut - more resources